CVC  Intuitive Venture Partners

https://www.intuitivevp.com/





     Office Locations:

777 Westchester Ave. Suite 101
White Plains, NY 10604
Phone: 212-612-3221
Fax: 212-661-8786

 

Stages:

  • Middle Market


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Software & Internet

  •  

    Description:

    Intuitive Venture Partners is a boutique venture investment company that specializes in the structuring, marketing and execution of private placements of equity and debt securities for both private and public companies. The firm invests in technology and healthcare industries. Intuitive Venture Partners is involved in Private Placements, Alternative Public Offerings, PIPEs, Registered, Direct Offerings (RDO), Pre-IPO Financings, Capital Markets Advisory, and Strategic Advisory services. The firm announced (December 2023) the close of $150 million for its second fund. In 2020, Intuitive Surgical launched a separately-chartered entity, Intuitive Ventures, funding its inaugural $100 million financially-motivated fund. The Founding Partners have worked together for over 20 years and have collectively raised over $1 billion for 300+ companies through seed, growth and late-stage financings.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Aaron M. Segal Partner & Co-Founder
    David G. Landskowsky Partner & Co-Founder
    Eric M. Rubenstein Partner & Co-Founder
    Scott T. Cardone Partner & Co-Founder
    Timothy J. Herrmann Partner & Co-Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/20/2023


      SURGE Therapeutics


      MA


      $32,000,000


      Series B


     

    Portfolio companies include:


      Capstan


      Endogenex


      Flywheel


      KelaHealth


      MedCrypt
        web link


      Optellum


      PeerNova


      Roambee
        web link


      SURGE Therapeutics
        web link


     

    Recent News: